Morgan Stanley raised the firm’s price target on West Pharmaceutical (WST) to $315 from $285 and keeps an Equal Weight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WST:
- West Pharmaceutical price target raised to $310 from $275 at Barclays
- The Week That Was, The Week Ahead: Macro and Markets, April 26
- West Pharmaceutical price target raised to $400 from $375 at Citi
- West Pharmaceutical price target raised to $390 from $320 at Evercore ISI
- West Pharmaceutical Lifts Outlook After Powerful Q1